These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1200 related items for PubMed ID: 17661150

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Multicystic peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Sironi A, Cabras A, Fumagalli L, Laterza B, Deraco M.
    In Vivo; 2008; 22(1):153-7. PubMed ID: 18396799
    [Abstract] [Full Text] [Related]

  • 3. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Baratti D, Vaira M, Kusamura S, D'Amico S, Balestra MR, Cioppa T, Mingrone E, De Simone M, Deraco M.
    Eur J Surg Oncol; 2010 Nov; 36(11):1047-53. PubMed ID: 20832234
    [Abstract] [Full Text] [Related]

  • 4. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [Abstract] [Full Text] [Related]

  • 5. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S.
    J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
    [Abstract] [Full Text] [Related]

  • 6. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.
    Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA.
    Ann Surg Oncol; 2004 Apr; 11(4):375-9. PubMed ID: 15070596
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC, Yan TD, Morris DL.
    J Surg Oncol; 2009 Feb 01; 99(2):109-13. PubMed ID: 19016259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.
    In Vivo; 2010 Feb 01; 24(1):79-84. PubMed ID: 20133981
    [Abstract] [Full Text] [Related]

  • 15. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
    Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA.
    Br J Surg; 2001 Mar 01; 88(3):458-63. PubMed ID: 11260116
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Malignant peritoneal mesothelioma.
    Bani-Hani KE, Gharaibeh KA.
    J Surg Oncol; 2005 Jul 01; 91(1):17-25. PubMed ID: 15999348
    [Abstract] [Full Text] [Related]

  • 19. Aggressive locoregional management of recurrent peritoneal sarcomatosis.
    Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA.
    J Surg Oncol; 2013 Mar 01; 107(4):329-34. PubMed ID: 23386388
    [Abstract] [Full Text] [Related]

  • 20. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M.
    Eur J Cancer; 2013 Oct 01; 49(15):3140-8. PubMed ID: 23831335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.